ID

27536

Description

Study Part: Study Conclusion Follow- Up (Visit 10). An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Keywords

  1. 11/19/17 11/19/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

November 19, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Study Conclusion Follow- Up (Visit 10) Ropinirole Parkinson Disease 101468/165

Study Conclusion Follow- Up (Visit 10)

STUDY CONCLUSION
Description

STUDY CONCLUSION

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Subject Number
Description

Subject Number

Data type

text

Alias
UMLS CUI [1]
C2348585
Did the subject complete the study as planned?
Description

Study Conclusion

Data type

boolean

Alias
UMLS CUI [1,1]
C1707478
UMLS CUI [1,2]
C0008972
If ’NO’, mark the one most appropriate category
Description

Study Conclusion

Data type

integer

Alias
UMLS CUI [1,1]
C1707478
UMLS CUI [1,2]
C0008972
Other, Please specify
Description

Other

Data type

text

Alias
UMLS CUI [1]
C0205394
Comments on reason for withdrawal:
Description

Comment reason for withdrawal

Data type

text

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C2349954
UMLS CUI [1,3]
C0392360
UMLS CUI [1,4]
C0008976
Date of Withdrawal:
Description

Date of Withdrawal

Data type

date

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0011008
Time of Withdrawal:
Description

Time of Withdrawal

Data type

time

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0040223
Date of Final Dose:
Description

Date of Final Dose

Data type

date

Alias
UMLS CUI [1]
C1531784
Time of Final Dose:
Description

Time of Final Dose

Data type

time

Alias
UMLS CUI [1]
C0946444

Similar models

Study Conclusion Follow- Up (Visit 10)

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
STUDY CONCLUSION
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Subject Number
Item
Subject Number
text
C2348585 (UMLS CUI [1])
Study Conclusion
Item
Did the subject complete the study as planned?
boolean
C1707478 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
Item
If ’NO’, mark the one most appropriate category
integer
C1707478 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
Code List
If ’NO’, mark the one most appropriate category
CL Item
Adverse Event (complete Adverse Event Form) (1)
C0877248 (UMLS CUI-1)
(Comment:en)
CL Item
Insufficient therapeutic effect (2)
C1527144 (UMLS CUI-1)
(Comment:en)
CL Item
Deviation from Protocol (including non-compliance) (3)
C1321605 (UMLS CUI-1)
(Comment:en)
CL Item
Lost to Follow-Up (4)
C1302313 (UMLS CUI-1)
(Comment:en)
CL Item
Other (5)
C0205394 (UMLS CUI-1)
(Comment:en)
Other
Item
Other, Please specify
text
C0205394 (UMLS CUI [1])
Comment reason for withdrawal
Item
Comments on reason for withdrawal:
text
C0947611 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
Date of Withdrawal
Item
Date of Withdrawal:
date
C2349954 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Time of Withdrawal
Item
Time of Withdrawal:
time
C2349954 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Date of Final Dose
Item
Date of Final Dose:
date
C1531784 (UMLS CUI [1])
Time of Final Dose
Item
Time of Final Dose:
time
C0946444 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial